Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Sarepta Therapeutics Inc
Today
Create an eToro account to buy SRPT stock on a secure, user-friendly, multi-asset trading platform.
Buy Sarepta Therapeutics Inc
SRPT Price
Sarepta Therapeutics Inc SRPT
Buy SRPT

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Sarepta Therapeutics Inc News

SRPT Price

Sarepta Therapeutics Inc SRPT

$118.570.14(0.12%)(1D)

SRPT Stock Price Chart

-5.57%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Sarepta Therapeutics Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Sarepta Therapeutics Inc share price today is 118.57, reflecting a 0.12% change over the last 24 hours and -4.58% over the past week. The current market capitalization of SRPT is 11.35B with an average volume in the last three months of 945695.35. The stock has a P/E ratio of 98.71 and a dividend yield of 0%. With the stock’s beta sitting at 0.82
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$11.35B
Day’s Range
i
Shows the high and low prices of the day.
115.98 - 129.53
52W Range
i
Shows the high and low prices of the last year.
55.15 - 172.67
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
945695.35
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
98.71
Revenue
i
The total income generated by this company’s goods and services last year.
$1.64B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$118.83
EPS
i
A company’s total earnings divided by the number of shares it has issued.
1.2
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.82
What Is Sarepta Therapeutics Inc?
Sarepta Therapeutics, Inc. is a biopharmaceutical company that specialises in developing solutions for rare neuromuscular diseases. The company is a leader in the field of precision genetic medicine, with its core activities focused in gene therapy, gene editing, and RNA technologies. Sarepta Therapeutics was founded in 1980 under its original name of AntiVirals, Inc. It changed its areas of specialism, and its name, first to AVI BioPharma in 1997, before rebranding as Sarepta Therapeutics, Inc. in 2012. Operating globally, the company employs over 850 people and has offices in France, Germany, Ireland, Switzerland, and the UK, with its headquarters in Cambridge, Massachusetts.

The genetic diseases that Sarepta Therapeutics focuses on include Duchenne muscular dystrophy, limb-girdle muscular dystrophy, mucopolysaccharidosis IIIA, and Charcot-Marie-Tooth disease. Sarepta Therapeutics has over 40 therapies in various stages of development. Current products include Exondys 51, Vyondys 53, and Amondys 45.

Sarepta Therapeutics, Inc. trades using the ticker SRPT on the NASDAQ. The company partners with a range of companies, including AavantiBio, Inc., Dyno Therapeutics, Lysogene, and Roche. It also works closely with several universities, including Columbia University, Harvard University, and the University of Western Australia.

Add SRPT stock to your eToro watchlist and stay up to date with all the latest news and stock value changes.
Buy SRPT

How can I buy Sarepta Therapeutics Inc stocks?

To purchase Sarepta Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Sarepta Therapeutics Inc (SRPT) page and place an order to buy Sarepta Therapeutics Inc.
Buy SRPT
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Sarepta Therapeutics Inc
Invest in Sarepta Therapeutics Inc
Today
Create an eToro account to buy SRPT stock on a secure, user-friendly, multi-asset trading platform.
Buy SRPT

FAQ

The current price of SRPT is 118.57.
The average price target for Sarepta Therapeutics Inc is 118.57. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Sarepta Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Sarepta Therapeutics Inc is 11.35B
Daily Movers
Explore the biggest stocks movers on the market.
Buy SRPT
Scroll to top